The V103I polymorphism of the MC4R gene and obesity: Population based studies and meta-analysis of 29 563 individuals

International Journal of Obesity

Volumn 31, Issue 9, 2007, Pages 1437-1441

  Young, E H ^a   Wareham, N J ^a   Farooqi, S ^b   Hinney, A ^c   Hebebrand, J ^c   Scherag, A ^d   O'Rahilly, S ^b   Barroso, I ^e   Sandhu, M S ^a,f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Genetics; MC4R; Meta analysis; Polymorphism

Indexed keywords

MELANOCORTIN 4 RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

ALLELES; BODY MASS INDEX; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 34547831224     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803609     Document Type: Article

References (34)

1. Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095.
2. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000; 106: 253-262.
3. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S et al. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 2004; 74: 572-581.
4. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182.
5. Ioannidis JPA, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003; 361: 567-571.
6. Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999; 80 (Suppl 1): 95-103.
7. Williams DRR, Wareham NJ, Brown DC, Byrne CD, Clark PMS, Cox BD et al. Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 1995; 12: 30-35.
8. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 1999; 22: 262-270.
9. Gotoda T, Scott J, Aitman TJ. Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association with obesity, plasma glucose, or insulin. Diabetologia 1997; 40: 976-979.
10. Gu W, Tu Z, Kleyn PW, Kissebah A, Duprat L, Lee J et al. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999; 48: 635-639.
11. Ohshiro Y, Sanke T, Ueda K, Shimajiri Y, Nakagawa T, Tsunoda K et al. Molecular scanning for mutations in the melanocortin-4 receptor gene in obese/diabetic Japanese. Ann Hum Genet 1999; 63: 483-487.
12. Dubern B, Clement K, Pelloux V, Froguel P, Girardet J-P, Guy-Grand B et al. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 2001; 139: 204-209.
13. Rosmond R, Chagnon M, Bouchard C, Bjorntorp P. A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol. Diabetologia 2001; 44: 1335-1338.
14. Miraglia del Giudice E, Cirillo G, Nigro V, Santoro N, D'Urso L, Raimondo P et al. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes 2002; 26: 647-651.
15. Jacobson P, Ukkola O, Rankinen T, Snyder EE, Leon AS, Rao DC et al. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis Cohort. J Clin Endocrinol Metab 2002; 87: 4442-4446.
16. Branson R, Potoczna N, Kral JG, Lentes K-U, Hoehe MR, Horber FF. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 348: 1096-1103.
17. Marti A, Corbalan MS, Forga L, Martinez JA, Hinney A, Hebebrand J. A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population. Int J Obes 2003; 27: 385-388.
18. Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L, Hollenberg AN, Kontula K, Bjorbaek C et al. Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults. J Clin Endocrinol Metab 2004; 89: 940-945.
19. Santini F, Maffei M, Ceccarini G, Pelosini C, Scartabelli G, Rosellini V et al. Genetic screening for melanocortin-4 receptor mutations in a cohort of Italian obese patients: description and functional characterization of a novel mutation. J Clin Endocrinol Metab 2004; 89: 904-908.
20. Rutanen J, Pihlajamaki J, Karhapaa P, Vauhkonen I, Kuusisto J, Moilanen Mykkanen L et al. The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain. Obes Res 2004; 12: 1060-1066.
21. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 2005; 90: 219-224.
22. Loos RJF, Rankinen T, Tremblay A, Pérusse L, Chagnon Y, Bouchard C. Melanocortin-4 receptor gene and physical activity in the Québec Family Study. Int J Obes 2005; 29: 420-428.
23. Heid IM, Vollmert C, Hinney A, Doring A, Geller F, Lowel H et al. Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet 2005; 42: e21.
24. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, Wermter A-K et al. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 2003; 88: 4258-4267.
25. Ho G, MacKenzie RG. Functional characterization of mutations in melanocortin-4 receptor associated with human obesity. J Biol Chem 1999; 274: 35816-35822.
26. Xiang Z, Litherland SA, Sorensen NB, Wood MS, Shaw AM, Millard WJ et al. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 2006; 45: 7277-7288.
27. Bewick GA, Gardiner JV, Dhillo WS, Kent AS, White NE, Webster Z et al. Postembryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J 2005; 19: 1680-1682.
28. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL. Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 1997; 17: 273-274.
29. Ollmann MM, Wilson BD, Yang Y-K, Kerns JA, Chen Y, Gantz I et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278: 135-138.
30. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671.
31. Farooqi IS, Yeo GSH, Keogh JM, Aminian S, Jebb SA, Butler G et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271-279.
32. Hinney A, Schmidt A, Nottebom K, Heibult O, Becker I, Ziegler A et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999; 84: 1483-1486.
33. Herpertz S, SiffertW, Hebebrand J. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 349: 606-607.
34. Hebebrand J, Geller F, Dempfle A, Heinzel-Gutenbrunner M, Raab M, Gerber G et al. Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations. Mol Psychiatry 2004; 9: 796-800.